1546-0096-9-S1-P971546-0096 Poster presentation <p>Outcome of children with panarteritis nodosa: a series of 30 cases</p> MerlinEe_merlin@chu-clermontferrand.fr MouyR QuartierP

CHU Clermont-Ferrand, INSERM CIC 501, 63003 Clermont-Ferrand, France

Hopital Necker, AP-HP, Paris, France

Pediatric Rheumatology <p>Proceedings of 18th Pediatric Rheumatology European Society (PReS) Congress</p>Rolando Cimaz, Pavla Dolezalova, Marco Gattorno, Hermann Girschick, Michael Hofer, Sue Maillard, Alberto Martini, Pierre Quartier, Carlos Rose, Johannes Roth, Rebecca ten Cate and Carine Wouters.Meeting abstracts - A single PDF containing all abstracts in this supplement is available here.<p>18th Pediatric Rheumatology European Society (PReS) Congress</p>Bruges, Belgium14-18 September 2011www.pres2011.eu1546-0096 2011 9 Suppl 1 P97 http://www.ped-rheum.com/content/9/S1/P97 10.1186/1546-0096-9-S1-P97
1492011 2011Merlin et al; licensee BioMed Central Ltd.This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Background

Childhood panarteris nodosa (PAN) is a rare vasculitis. Cutaneous and systemic forms are distinguished based on systemic involvement.

Patients and methods

We recorded the data of children who were diagnosed as PAN in Necker Hospital between 1986 and 2006. Patients were classified as systemic PAN if at least one of the following organs was involved: central or peripheral nervous system, testis, kidney, lungs, heart or gastro-intestinal tract. Data are shown as median and range.

Results

30 patients (20 girls, 10 boys) aged 7.2 years (2-14) were included. 29 had fever and all 30 had marked asthenia. The organs involved at diagnosis were: skin (24/30), muscle (12/30), nervous system (peripheral 4/30, lymphocytic meningitis 2/30), abdominal pain (6/30), kidney (2/30). Eleven children had an initial systemic presentation. All children had marked inflammatory syndrome. Sixteen had evidence of necrotizing panarteritis on histology, 14 had atypical features without necrosis. Angiography was performed in 2 patients and was normal. First-line therapy consisted in NSAID alone in 8 patients, IgIV in 4, steroids in 18. Overall, 6 patients did never need steroids, 8 patients needed cyclophosphamide. After 70 months of follow-up (7-178), 29 patients were alive, 24 disease-free (16 treatment-free), 5 with active disease, 1 patient died from sepsis. Patients with cutaneous form without histological necrosis had a better outcome. Four patients with initial cutaneous presentation subsequently developed systemic manifestations.

Conclusion

The prognosis of pediatric PAN may be linked to both clinical and histological features.